Stay updated on Safety Efficacy of NASH Drugs in Compensated Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy of NASH Drugs in Compensated Cirrhosis Clinical Trial page.

Latest updates to the Safety Efficacy of NASH Drugs in Compensated Cirrhosis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision v3.3.2 is added and an older revision v3.2.0 is removed from the record history, indicating an internal versioning update with no changes to study content or status.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the general government funding/operating status banner that previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check43 days agoChange DetectedAn additional version entry (v22, 2020-12-01) is added to the Record History page, indicating a minor update to the record while core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference11%

- Check79 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.3%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed. This is a minor update with no changes to core content or live data.SummaryDifference0.6%

Stay in the know with updates to Safety Efficacy of NASH Drugs in Compensated Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy of NASH Drugs in Compensated Cirrhosis Clinical Trial page.